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The goal of this study was to investigate the specific patterns of memory breakdown in 
patients suffering from early-onset Alzheimer’s disease (EOAD) and late-onset 
Alzheimer’s disease (LOAD). Twenty EOAD patients, twenty LOAD patients, twenty 
matched younger controls, and twenty matched older controls participated in this study. 
All participants underwent a detailed neuropsychological assessment, an MRI scan, an 
FDG-PET scan, and AD patients had biomarkers as supporting evidence of both 
amyloïdopathy and neuronal injury. Results of the neuropsychological assessment 
showed that both EOAD and LOAD groups were impaired in the domains of memory, 
executive functions, language, praxis, and visuoconstructional abilities, when compared 
to their respective control groups. EOAD and LOAD groups, however, showed distinct 
patterns of memory impairment. Even though both groups were similarly affected on 
measures of episodic, short term and working memory, in contrast semantic memory was 
significantly more impaired in LOAD than in EOAD patients. The EOAD group was not 
more affected than the LOAD group in any memory domain. EOAD patients, however, 
showed significantly poorer performance in other cognitive domains including executive 
functions and visuoconstructional abilities. A more detailed analysis of the pattern of 
semantic memory performance among patient groups revealed that the LOAD was more 
profoundly impaired, in tasks of both spontaneous recall and semantic recognition. 
Voxel-Based Morphometry (VBM) analyses showed that impaired semantic performance 
in patients was associated with reduced gray matter volume in the anterior temporal lobe 
region, while PET-FDG analyses revealed that poorer semantic performance was 
associated with greater hypometabolism in the left temporoparietal region, both areas 
reflecting key regions of the semantic network. Results of this study indicate that EOAD 
and LOAD patients present with distinct patterns of memory impairment, and that a 









Alzheimer’s disease (AD) accounts for approximately 60% of all dementia cases. 
Typically memory is the cognitive domain that is affected foremost and that remains 
impaired most severely throughout the course of AD. Episodic memory impairment is 
considered as the core clinical feature of AD and begins in the earliest stages of the 
disease, although semantic memory and working memory are also impaired. Deficits in 
episodic memory can be evidenced using neuropsychological tests that require 
remembering word lists, figures and faces over a period of time ranging from several 
minutes to one week. Impairment in delayed recall seems to be one of the best predictors 
of future dementia (Small et al., 2000; Ivanoiu et al., 2005). Semantic memory, which 
concerns general world knowledge, is also impaired in AD, even at the pre-dementia 
stages of the disease (Chertkow and Bub, 1990; Duong et al., 2006; Joubert et al., 2010). 
Semantic deficits have been documented in AD using a variety of standard clinical 
neuropsychological tests (Huff et al., 1986; Rosser and Hodges, 1994; Hodges and 
Patterson, 1995; Adlam et al., 2006) and using more specific measures (Chertkow and 
Bub, 1990; Hodges et al., 1992; Greene and Hodges, 1996; Fung et al., 2001; Thompson 
et al., 2002; Whatmough et al., 2003; Joubert et al., 2010). Working memory deficits are 
also frequently reported in AD and involve reduced span for words, digits, letters and 
spatial locations (Grossi et al., 1993; Belleville et al., 1996). Beyond the memory 
impairment, other aspects of cognitive function are also altered in the clinical course of 
AD. For instance, executive dysfunction is an early manifestation of AD (Binetti et al., 
1996). It affects inhibition (Collette et al., 1999), mental flexibility and set-shifting 
(Haxby et al., 1988; Lafleche and Albert, 1995; Albert et al., 2001), planning abilities, 
and attention (Pate et al., 1994; Perry and Hodges, 1999; Rizzo et al., 2000; Baddeley et 
al., 2001; Slavin et al., 2002; Pignatti et al., 2005). Specific language deficits including 
anomia are also common in AD and become exacerbated as the disease advances 
(Kempler, 2005). Other cognitive deficits such as visuoconstructional apraxia also occur 
in AD (Ajurriaguerra et al., 1960; Edwards et al., 1991; Rosen et al., 2005), although 
they are usually less important than memory impairment and executive dysfunction. In 
terms of the staging of cognitive deficits in AD, it is commonly accepted that episodic 
memory is first impaired in AD, followed by semantic, executive and attentional deficits, 
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and later on by linguistic and visuospatial impairments (Perry et al., 2000; Lambon Ralph 
et al., 2003; Joubert et al., 2007).  
 Even though age is the primary risk factor for developing AD, the disease can occur 
at different stages of life. The concept of early-onset AD (EOAD) commonly refers to 
AD patients who develop the first symptoms before the age of 65. Although early-onset 
and late-onset AD (>65) (LOAD) are assumed to share common neuropathological 
features (Braak and Braak, 1991), refer to a common disease and are diagnosed on the 
same clinical grounds (McKhann et al., 1984), there is increasing evidence that EOAD 
patients present with distinct patterns of cognitive impairment relative to LOAD patients. 
The variability in clinical presentation between EOAD and LOAD patients may be due to 
in part to inherently subtle differences in the underlying topological distribution of 
atrophy within the medial temporal lobe and neocortical structures. In fact, atrophy may 
not be as prevalent within medial temporal lobe structures in EOAD as in LOAD but may 
be over-represented in neocortical structures, including the parietal cortex, the prefrontal 
cortex and the anterior temporal lobes (Poncet et al., 2006). This has been confirmed by 
recent studies which have shown that early and late-onset AD patients show different 
patterns of cortical atrophy, brain metabolism, and functional connectivity, likely due to 
differences in the distribution of underlying pathological changes (Felician and Pellissier, 
2005; Gour et al., 2013).   
 It was first reported (Delay and Brion, 1962) that younger AD patients presented 
with an inaugural memory impairment, rapidly followed by a severe deficits of cortical 
functions (aphasia, apraxia, and agnosia), the latter reflecting the more striking clinical 
feature in these patients. The authors also insisted on the relatively brief evolution of the 
disease (2-4 years from onset of dementia). In contrast, they reported that older AD 
patients showed a slower overall decline and deficits predominated in the memory 
domain, while functions such as language and praxis usually remained preserved. Briefer 
evolution in early-onset patients was later confirmed (Jacobs et al., 1994), but there have 
been conflicting results in the literature regarding the nature of the cognitive decline. 
Several studies did not find any distinctive differences between EOAD and LOAD 
patients (Cummings et al., 1985; Bayles et al., 1987; Grady et al., 1987; Selnes et al., 
1988; Toyota et al., 2007) or have attributed such differences to dementia severity 
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(Jacobs et al., 1994; Smits et al., 2012). Regarding memory, a relative sparing of memory 
in EOAD has been reported (Binetti et al., 1996; Smits et al., 2012), while several studies 
have found that LOAD patients present primarily with memory difficulties (Jacobs et al., 
1994; Imamura et al., 1998). Several studies also found that language function was more 
altered in early-onset patients (Chui et al., 1985; Filley et al., 1986; Becker et al., 1988; 
Faber-Langendoen et al., 1988; Binetti et al., 1996; Imamura et al., 1998), even when 
factors such as education and severity of dementia were controlled for, while variable 
findings were reported regarding the presence of apraxia (Seltzer and Sherwin, 1983; 
Reid et al., 1996). A more recent neuropsychological study reported that mildly 
demented EOAD patients performed worse than LOAD patients on visuospatial 
functioning, executive functioning, and attention, while memory was remarkably 
preserved (Smits et al., 2012). Other studies have also reported that early-onset patients 
have significant visuospatial difficulties when compared to late-onset patients (Fujimori 
et al., 1998; Koedam et al., 2010). In summary, there have been conflicting results in the 
literature regarding the patterns of cognitive dysfunction in EOAD and LOAD, but taken 
together results of these studies seem to suggest that EOAD patients have more 
prominent difficulties in non-memory domains which include language, visuospatial 
skills, and executive functions. The absence of consensus may be due to several factors: 
1) cognitive evaluations of EOAD and LOAD patients in previous studies were often 
brief and limited to general domains such as memory and executive functions, while 
other domains were often not tested (Smits et al., 2012); 2) differences in disease stage 
may not have been taken into account; 3) variability in the tests used to evaluate specific 
cognitive domains; 4) specific subdomains were not considered (e.g. memory), possibly 
eluding differences between EOAD and LOAD groups. 
 One question of critical importance is whether EOAD and LOAD patients show 
distinct patterns of impairment within different memory domains. To our knowledge, the 
question of whether memory subdomains such as episodic memory, semantic memory, 
short-term memory, and working memory, are affected differently in EOAD and LOAD 
has never been investigated previously. Therefore, the main objective of this study is to 
investigate different memory subdomains in EOAD and LOAD using a detailed battery 
of neuropsychological tests, in order to gain a better understanding of the precise nature 
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of the memory deficits in these groups. A secondary objective is also to assess 
neuropsychological performance of patients and age-matched controls across a number of 
other cognitive domains including executive functions, language, visuoperceptual 
abilities, visuospatial abilities, visuoconstructional abilities, and praxis. This may allow 
gaining a clearer picture of the nature of the cognitive impairment in the early stage of 
EOAD and LOAD. It is hypothesized that LOAD patients will present with more 
important deficits in working memory, episodic memory and semantic memory when 
compared to EOAD patients, while the latter group will show more important deficits in 
non-memory domains such as language and visuospatial abilities. Finally, a corollary 
goal of this study is to better pinpoint the brain regions associated with decline in specific 
memory subsystems by investigating relationships between patterns of cortical atrophy 
and brain metabolism, using Voxel-based Morphometry (VBM) and Positron emission 
tomography (PET-FDG), and patterns of memory impairment emerging in EOAD and 
LOAD patients.  
 
 
2. Material and Methods 
2.1. Subjects 
Eighty subjects participated in the current study: twenty EOAD patients, twenty LOAD 
patients, and two groups of twenty healthy controls matched for age and education to 
each of the patient groups. All subjects provided informed consent to participate in the 
study. The research protocol was approved by the local Research Ethics Committee.  
EOAD and LOAD patients were recruited at the Memory clinic of the Neurology 
and Neuropsychology Unit in the Timone Hospital, Marseille. All patients underwent a 
neurological examination, a neuropsychological assessment, a brain MRI and laboratory 
workup to rule out nondegenerative causes of cognitive impairment. The diagnosis of 
probable AD was established by a team of trained neurologists and neuropsychologists 
following consensus meetings based on past and recent recommendations (McKhann et 
al., 1984; McKhann et al., 2011). Age of onset was estimated using a structured 
interview of the patient and caregiver. All patients had dementia of mild severity, with 
deficits involving memory and other cognitive domains. In order to avoid misdiagnosis in 
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early and late-onset AD, only probable AD patients with a high level of supporting 
evidence in favor of a pathophysiological process were included (i.e. clinical criteria for 
probable AD and biomarkers showing evidence of both amyloïdopathy and neuronal 
injury) (McKhann et al., 2011). Consequently, Cerebro Spinal Fluid (CSF) analysis was 
performed in all patients prior to inclusion. CSF was subjected to usual procedures (cell 
counts, total protein levels, CSF / serum albumin ratio and oligoclonal bands). Total Tau, 
P-Tau 181 and Aβ42 peptide levels were determined using ELISA, the Innotest-h Tau-
Ag-kit, the Innotest Phospho-Tau (181P) kit and the Innotest Aβ42 kit respectively 
(Innogenetics, Ghent, Belgium).  
Clinical inclusion criteria were probable amnestic AD with high level of evidence 
of AD pathophysiological process, such as determined by Innotest Amyloid Tau Index 
(IATI) < 0.8 and P-Tau > 60 (an optimal combination of CSF biomarkers that predicts 
AD with a specificity of 95% and a sensitivity of 85%) (Vanderstichele et al., 2006); 
presence of a reliable informant; mild dementia severity (Clinical Dementia Rating – 
CDR of 1) (Morris, 1993); onset of symptoms ranging from 1 to 5 years prior to 
inclusion; no personal history of neurological or psychiatric disorder; no family history of 
AD that could suggest autosomal dominant inheritance; no abnormal feature on brain 
MRI including stroke, more than one ischemic lacuna, and white matter changes on 
FLAIR, above grade 2 at the Fazecas scale (Fazekas et al., 1987; Gour et al., 2013). 
Patients with non-amnestic clinical presentations of AD such as logopenic aphasia or 
posterior cortical atrophy were excluded. The subgroups of AD patients were classified 
based on a determined cut-off of 65 years of age at onset, based on previous studies 
comparing features of EOAD and LOAD patients (Kemp et al., 2003; Kim et al., 2005; 
Shiino et al., 2006; Frisoni et al., 2007; Rabinovici et al., 2010; Canu et al., 2012; Sa et 
al., 2012; Smits et al., 2012; Cho et al., 2013), as well as on clinical grounds (Amaducci 
et al., 1986). This cut-off is also used in the DSM-IV TR nomenclature to specify 
subtypes (American Psychiatric Association, 2000). See Table 1 for details on the results 
of biomarkers in this study. 
 
INSERT TABLE 1 ABOUT HERE 
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The group of EOAD patients included twelve females and eight males (CDR = 1; 
MMSE = 21 (3.7), mean age: 60.6 (5.2), mean number of years since onset of disease: 2.9 
(1.0); mean number of years of education: 11.6 (2.7)) and the group of LOAD included 
twelve females and eight males (CDR = 1, MMSE = 22 (3.2), mean age: 77.9 (4.7), mean 
number of years since onset: 2.8 (1.2); mean number of years of education: 11.3 (3.5)). 
Two groups of twenty healthy control participants were matched for age and education 
with the two patient groups (Younger controls: 14 females/6 males; CDR = 0, MMSE = 
29 (0.9), mean age = 57.1 (6.4), mean number of years of education: 13.1 (2.1); Older 
controls: 13 females/7 males; CDR = 0, MMSE = 29 (0.6), mean age = 75.6 (5.7), mean 
number of years of education: 11.3 (3.5)). Controls had no history of neurological or 
psychiatric disorder, no cognitive complaint, normal neuropsychological performance 
and no abnormal feature on structural brain MRI and 18-FDG-PET imaging. Patients and 
controls underwent a full neurological examination, a detailed neuropsychological 
assessment, brain MRI and 18-PET-FDG. Apo E genotype was obtained in all subjects 
using Hha 1 digestion and electrophoresis analysis. Within the context of a functional 
connectivity study, part of the neuroimaging and clinical data of a subgroup of 
participants from the current study were published recently (Gour et al., 2013).   
Statistical analyses showed that the EOAD and LOAD groups did not differ 
between each other in terms of general cognitive level such as assessed by MMSE score 
(t-test, t = 1.23, p = 0.22), number of years of education (t = 0.30, p = 0.76), number of 
years since onset of disease (t = 0.42, p=0.67), and gender (Fischer’s exact test, p=1.0). In 
addition, the EOAD and LOAD groups did not differ significantly from their respective 
control group in terms of age and education (LOAD vs. older controls: age, t = 1.48, p = 
0.15; education, t = 0.45, p = 0.96; gender, Fischer’s exact test, p = 1.0; EOAD vs. 
younger controls: age, t = 1.87, p = 0.07; education, t = 1.96, p = 0.06; gender, Fischer’s 
exact test, p = 0.74). As expected, however, both AD groups differed from their 
respective control group in terms of MMSE score (EOAD: t = 9.95, p<0.01; LOAD: t = 
9.9, p<0.01). Regarding biomarkers, there were no significant differences between 
EOAD and LOAD groups with respect to total Tau (t = 0.40, p=0.69), P-Tau 181 (t = 
1.52, p=0.14), Aβ42 (t = 1.08, p=0.29), IATI (t = 0.53, p=0.60), nor were there 
differences in terms of Apo E4 status (Fischer’s exact test, p = 0.69). Results therefore 
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confirm that there were no significant differences in terms of biomarkers between EOAD 
and LOAD patients, that both groups present with a similar high frequency of Apo E4 
carriers, and that there is a high level of supporting evidence in favor of a diagnosis of 
AD in early-onset and late-onset patients. 
 
2.2. Neuropsychology 
All three groups of participants underwent a comprehensive neuropsychological 
assessment, which included neuropsychological measures of memory, attention and 
executive functions, language, visuoperceptual skills, visuospatial skills, visuo-
constructional skills, and praxis. General cognitive abilities were assessed using the Mini-
mental State Examination (MMSE)(Folstein et al., 1975) and the Batterie rapide 
d’évaluation frontale (BREF/FAB)(Dubois et al., 2000). In terms of memory, episodic 
memory (anterograde memory) was assessed both in the verbal and visual domains. 
Verbal memory was assessed with the RL/RI 16 (Van der Linden et al., 2004), a 
free/cued word recall test widely used as a measure of verbal learning in French similar 
to the free and cued selective reminding test (FCSRT) (Grober et al., 1988). Visual 
memory was assessed using the Delayed Matching to Sample test (DMS48), a visual 
recognition memory test widely used in the assessment of MCI and dementia (Barbeau et 
al., 2004). Semantic memory (retrograde memory) was assessed using the TOP 10 
(Thomas-Anterion and Puel, 2006). The TOP 10 is a standardized test evaluating famous 
person knowledge of 10 celebrities who were famous between the 1950s and 2000s. This 
semantic test comprises several sections, including spontaneous recall of biographical 
knowledge about famous persons (name and occupation), recognition such as assessed 
through multiple choice questions (name and occupation), specific questions about each 
individual, and assessing the approximate epoch of fame for each famous person. Tests of 
famous person knowledge have been shown to be very sensitive to assess semantic 
breakdown in patients suffering from AD and amnestic MCI (Estevez-Gonzalez et al., 
2004; Vogel et al., 2005; Joubert et al., 2008; Joubert et al., 2010; Barbeau et al., 2012; 
Brambati et al., 2012). Short term memory was assessed in the verbal and spatial 
domains using respectively the forward digit span of the Wechsler Adult Intelligence 
scale (Wechsler, 1997) and the forward visuospatial span of the Wechsler Memory Scale 
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(Weschler, 2001). Working memory was assessed in the verbal and spatial domains using 
respectively the backward digit span of the Wechsler Adult Intelligence scale (Wechsler, 
1997) and the backward visuospatial span of the Wechsler Memory Scale (Weschler, 
2001).  
 Executive functions were assessed using several tests which included the Trail 
Making Test part A (attention), the Trail Making Test part B (Reitan, 1955) and the 
modified Wisconsin Card Sorting Test (WCST) (Nelson, 1976 ) (cognitive flexibility and 
inhibition), as well as the Digit Symbol-Coding subtest of the Wechsler Adult 
Intelligence scale (processing speed) (Wechsler, 1997). Language tests included 
measures of naming, spontaneous speech, fluency, repetition, and comprehension. They 
included the DO80, a French standardized picture naming task (Deloche and Hannequin, 
1997), the Letter (P) and Category (animals) fluency tests (Cardebat et al., 1990), the 
Spontaneous speech subtest of the MEC (Joanette et al., 2004), repetition of abstract and 
concrete sentences (Kaplan and Adaptation française Mazeau, 1972), as well as the Logic 
and reasoning, Verbal commands, and Verbal discrimination subtests of the HDAE 
(Kaplan and Adaptation française Mazeau, 1972). Praxis were evaluated using the 
Batterie brève d’évaluation des praxies gestuelles (Mahieux-Laurent et al., 2009). The 
Benton line orientation test was employed to evaluate visuospatial abilities (Benton et al., 
1978), while the Benton Facial Recognition Test was used to assess visuoperceptual 
processing (Benton et al., 1983). Visuoconstructional abilities were assessed using the 
copy of the Rey–Osterrieth figure (Rey, 1960). 
 
2.3. Statistical analysis 
In regards to the neuropsychological tests, as a first step the following comparisons were 
carried out: EOAD vs. younger controls, LOAD vs. older controls, and EOAD vs. 
LOAD. The Kolmogorov-Smirnov test was used to assess normality of distribution. 
When distribution was normal, Student t-tests were carried out on the neuropsychological 
tests for the three group comparisons. Appropriate Bonferroni correction was applied to 
control for multiple comparisons. Since there were 40 variables for each group 
comparison (EOAD vs. LOAD, EOAD vs. YCTR, LOAD vs. OCTR), the threshold of 
statistical significance was set at p < 0.0013 (Bonferroni correction, p < 0.05/40). If the 
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distribution was not normally distributed, significant differences were analyzed using 
non-parametric Kolmogorov-Smirnov Z tests. SPSS Statistics 20 Software was used.  
As a second step, in order to address more specifically which memory 
subdomains and which cognitive domains were affected in each patient group when 
compared to their respective control group, composite z-scores were computed for the 
following memory subdomains: Verbal anterograde memory, visual anterograde memory, 
semantic retrograde memory, verbal short term memory, visuospatial short term memory, 
verbal working memory, and visuospatial working memory. In addition, composite z-
scores were computed for the following cognitive domains: executive functions, 
language, praxis, visuospatial abilities, visuoconstructional abilities, and visuoperceptual 
abilities. Composite z-scores for verbal anterograde memory were derived from delayed 
free and total recall scores at the RL/RI 16 test, while composite z-scores for visual 
anterograde memory were derived from delayed recall scores at the DMS48. Composite 
z-scores for semantic memory were derived from total scores at the TOP 10. Composite 
z-scores for verbal short term and working memory were calculated from forward and 
backward digit span scores of the WAIS-III, respectively, while composite z-scores for 
visuospatial short term and working memory were calculated from forward and backward 
visuospatial span scores of the WMS-III. Moreover, additional analyses were carried out 
to investigate if specific patterns or cognitive impairment emerged between groups. 
Composite scores for language were computed from naming, category fluency, repetition, 
and comprehension scores. Composite z-scores for praxis were derived from scores on 
the symbolic, action, and abstract subtests of the Praxis test. Composite z-scores for 
executive functions were derived from WCST number of sets and total error scores and 
letter fluency. Composite z-scores for visuoperceptual abilities were derived from total 
scores on the Benton Facial Recognition Test. Composite z-scores for visuospatial 
abilities were derived from total scores on the Benton Line Orientation Test. Finally, 
composite z-scores for visuoconstructional abilities were derived from total scores on the 
copy of the Rey-Osterrieth Figure. Missing values on the cognitive tests included: Rey 
copy - one EOAD patient; BFRT - one EOAD; BLOT - one EOAD and one LOAD; 
RL/RI 16 - four LOAD and seven EOAD; DMS48 - one EOAD; TOP10 - two EOAD 
and two LOAD; WCST - five EOAD and four LOAD;  HDAE comprehension – four 
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LOAD and two EOAD; Test of praxis - one LOAD. If a participant had not completed a 
specific test or subtest, cells were entered as missing values. If a participant had failed all 
trials of a test and was unable to complete this test, a score of zero was given. Individual 
z-scores were calculated as follows for each test: z-score = [(participant score – mean 
score for the age-matched control group)/standard deviation for the age-matched control 
group]. Individual patient z-scores were then averaged into a global patient group z-score 
(EOAD or LOAD) for each domain. Appropriate Bonferroni correction was applied to 
control for multiple comparisons. Concerning memory domains, the threshold of 
statistical significance was set at p < 0.007 (Bonferroni correction, p < 0.05/7). 
Concerning cognitive domains, the threshold of statistical significance was set at p < 
0.008 (Bonferroni correction, p < 0.05/6). 
        
2.4. MRI procedure and data processing  
Imaging was performed on a 3T Magnetom Verio MR Scanner (Siemens, Erlangen, 
Germany) equipped with a 12 channel head coil. Foam padding and headphones were 
used to limit head motion and reduce scanner noise. Conventional MRI included 3D 
MPRAGE T1-weighted images (TE/TR 2.99 ms/2,3000 ms, 144 contiguous slices, 
1.3mm slice thickness, field of view (FOV) 250 mm, matrix 256) acquired in the sagittal 
plane.  
To obtain gray matter (GM) tissue probability maps, 3D-T1 weighted magnetic resonance 
images were postprocessed using the VBM 8 implemented in SPM8 software (Welcome 
Trust Centre for Neuroimaging, London, UK). MRI data were spatially normalized (MNI 
space), segmented to isolate the GM partition, and modulated. The resulting images, 
expressed as GM volume corrected for brain size, were masked (75%) to remove 
remaining non-GM voxels and smoothed (FWHM 6 mm).   
Regression analyses were performed at voxel-level, using SPM 8, to study correlations 
between gray matter volume of EOAD and LOAD subjects and memory performance 
(mean composite z-scores for memory subdomains: DMS 48; TOP 10 and RL/RI 16 
tests). These regression were performed within patterns of atrophy in EAOD and LOAD 
relative to age-matched controls obtained from an ANOVA with two factors: Group (AD 
versus Controls) and Age (<65 years versus >65 years) (see supplementary Figure 1). 
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The SPM (T) maps were obtained at a threshold (voxel level significance) of p < 0.005, 
FDR corrected at the cluster level p<0.05, and using age, gender education level and sex 
as nuisance variables. MNI coordinates were converted into Talairach coordinates, and 




2.5. FDG-PET procedure and data processing  
PET scan was performed using an integrated PET/CT camera (Discovery ST, GE 
Healthcare, Waukesha, USA), with 6.2 mm axial resolution, allowing 47 contiguous 
transverse sections of the brain of 3.27 mm thickness. 150 MBq of 18FDG were injected 
intravenously in an awake and resting state, with eyes closed, in a quiet environment. 
Image acquisition started 30 min after injection and ended 15 min later. Images were 
reconstructed using ordered subsets expectation maximization algorithm, with 5 iterations 
and 32 subsets, and corrected for attenuation using CT transmission scan. 
 Whole-brain PET statistical analysis was performed at voxel-level using SPM8 
software, to study correlations between cerebral metabolic rate of glucose of EOAD and 
LOAD subjects and memory performance (mean composite z-scores for memory 
subdomains: DMS 48; TOP 10 and RL/RI 16 tests). These regression were performed 
within patterns of hypometabolism in EAOD and LOAD relative to age-matched controls 
obtained from an ANOVA with two factors: Group (AD versus Controls) and Age (<65 
years versus >65 years) (see supplementary Figure 2).  
 The PET images were spatially normalized onto the Montreal Neurological 
Institute atlas (MNI). The dimensions of the resulting voxel were 2 mm × 2 mm × 2 mm. 
The images were then smoothed with a Gaussian filter (8 mm FWHM) to blur individual 
variations anatomy and to increase signal-to-noise ratio. The “proportional scaling” 
routine was used to check for individual variations in global brain metabolism. The SPM 
(T) maps were obtained at a height threshold (voxel level significance) of p < 0.005, FDR 
corrected at the cluster level p<0.05, and using age, gender education level as nuisance 
variables. MNI coordinates were converted into Talairach coordinates, and brain 
structures were identified using Talairach Daemon database (http://www.talairach.org/). 




3. Results  
3.1. Neuropsychological data 
Results of the neuropsychological assessment are presented in Table 2. A legend at the 
bottom of Table 2 indicates when parametric and non-parametric tests were applied, as 
well as Bonferroni correction. Results show that when compared to their respective 
control group, both EOAD and LOAD groups were affected in most of the cognitive 
domains assessed, including episodic memory, semantic memory, short term memory, 
working memory, executive functions, language, praxis, and visuoconstructional abilities. 
When the EOAD and LOAD groups were compared to each other, however, the LOAD 
group was only found to be significantly more impaired than the EOAD group on the 
TOP 10, a test of semantic knowledge. Younger controls and older controls did not differ 
in terms of their performance on the TOP 10 (t = 1.0, p = 0.3), indicating that there was 
no significant effect of age on semantic performance. 
 
INSERT TABLE 2 ABOUT HERE 
  
In order to investigate more specifically the specific patterns of memory function 
in each patient group in relation to its respective control group, composite z-scores were 
computed for each memory domain. Results are presented in Figure 1. Results 
demonstrate that the LOAD group was significantly more impaired than the EOAD group 
in semantic memory (EOAD = -2.0 (1.0); LOAD = -3.7 (0.9); t = 5.23, p < 0.0001). 
There was also a trend toward significance regarding visual recognition memory (EOAD 
= -2.5 (3.3); LOAD = -5.3 (3.3); t = 2.70, p = 0.01). There were no differences between 
groups in verbal anterograde memory (EOAD = -15.4 (4.5); LOAD = -14.4 (4.6); t = 
0.55, p = 0.58), verbal short term memory (EOAD = -0.4 (1.3); LOAD = 0.1 (1.1); t = 
1.22, p = 0.23), verbal working memory (EOAD = -1.6 (1.5); LOAD = -1.2 (1.1); t = 1.0, 
p = 0.33), visuospatial short term memory (EOAD = -2.1 (1.0); LOAD = -1.3 (1.9); t = 
1.61, p = 0.12), or visuospatial working memory (EOAD = -1.6 (1.2); LOAD = -1.8 (1.6); 
t = 0.44, p = 0.67). In conclusion, the most striking difference between patient groups 
concerned semantic memory which was found to be disproportionately impaired in the 
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LOAD group. When looking at the individual performance of patients within each group 
on the semantic test, it was found that 100% of LOAD patients were significantly 
impaired (such as determined by a cut-off z-score of < -1.96), while only 50% of EOAD 
patients exhibited significant semantic memory deficits. 
 
INSERT FIG. 1 ABOUT HERE 
 
Composite z-scores were also computed for cognitive domains other than memory so 
as to report the specific patterns of cognitive impairment found in each patient group 
relative to its control group. Results are presented in Figure 2. Results show that the 
EOAD group was significantly more impaired relative to the LOAD group in two 
cognitive domains: executive functions (EOAD = -3.9, (2.5); LOAD = -1.3 (1.1);   t = 
3.7, p < 0.008), and visuoconstructional abilities (EOAD = -16.3 (11.0); LOAD = -3.2 
(3.8); t = 5.01, p < 0.008). In contrast, the LOAD group did not show significantly poorer 
performance than the EOAD group in any cognitive domain. Finally, the two groups of 
patients did not differ significantly in terms of praxis (EOAD = -6.0 (6.2); LOAD = -2.3 
(3.1); t = 2.30, p = 0.025), language (EOAD = -10.5 (6.2); LOAD = -7.6 (6.5); t = 1.33, p 
= 0.19), visuospatial skills (EOAD = -2.2 (2.4); LOAD = -1.1 (2.0); t = 1.55, p = 0.13), or 
visuoperceptual skills (EOAD = -0.5 (1.5); LOAD = -0.1 (0.5); t = 1.16, p = 0.25). 
 
INSERT FIG. 2 ABOUT HERE 
 
Based on the finding that LOAD patients performed significantly worse than 
EOAD patients on the semantic memory test, a more in-depth investigation of the 
patterns of semantic performance of patients was performed. In order to better document 
the pattern of semantic impairment in both groups of patients, two separate aspects of 
semantic performance were examined, raw scores on spontaneous recall of semantic 
knowledge (free recall) and scores on semantic recognition (multiple choice questions). 
Spontaneous recall involves effortful retrieval of stored conceptual knowledge, while in 
semantic recognition maximum contextual information is provided through multiple 
choice questions, thereby guiding and facilitating semantic decision. Although 
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dissociations in free recall vs. recognition of semantic knowledge do not allow to directly 
answer the question of whether semantic deficits are due to difficulties in accessing 
knowledge vs. breakdown of this knowledge, as would be the case with a semantic 
priming task (Giffard et al., 2002; Brambati et al., 2012), deficits in semantic recognition 
are nonetheless typically considered to reflect a more genuine breakdown of semantic 
knowledge (Joubert et al., 2010; Barbeau et al., 2012). As illustrated in Figure 3, the 
main finding was that EOAD were significantly more impaired relative to younger 
controls on the free recall (EOAD = 10.1 (3.4); YCTR = 16.3 (3.4); t = 5.58, p < 0.01) 
but not on the semantic recognition task (EOAD = 9.2 (1.2); YCTR = 9.6 (0.8); t = 1.39, 
p = 0.18) of the TOP 10, while LOAD were impaired both on the free recall (LOAD = 
4.5 (2.9); OCTR = 14.0 (3.6); t = 8.88, p < 0.01) and on the semantic recognition task 
(LOAD = 7.2 (1.5); OCTR = 9.4 (0.6); t = 5.89, p < 0.01) relative to their respective 
control group. LOAD patients were also overall more impaired than EOAD patients on 
the TOP 10 total score (EOAD = 31.9 (8.7); LOAD = 17.8 (6.8); t = 5.44, p < 0.01). 
Thus, these results support the notion that LOAD patients suffer from a more profound 
and genuine semantic impairment.  
 
INSERT FIG. 3 ABOUT HERE 
 
3.2. VBM results 
Regression analyses revealed a positive correlation between performance on TOP 10 
(total score) and gray matter volume of left inferior temporal gyrus (BA 21; k= 345; T-
score=4.09; p-voxel<0.001; Talairach coordinates x=-40, y=-5, z=-29) and left superior 
temporal pole (BA 38; k=568; T-score= 4.35 x=-40, y=5, z=-14). RL/RI 16 performance 
(verbal anterograde memory) and DMS48 performance (visual anterograde memory) 
were not significantly correlated with gray matter volume in any region. Results are 
presented in Figure 4A.  
 
INSERT FIG. 4A ABOUT HERE 
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Further analyses were carried out to investigate correlations between free recall and 
recognition of semantic knowledge on the TOP 10 and gray matter volume. Regression 
analyses revealed a positive correlation between free recall performance on the TOP 10 
and gray matter volume of the right inferior frontal cortex (BA47, Talairach coordinates 
x=47, y=7, z=-42), the right temporal pole (BA 38; Talairach coordinates x=45, y=-4, z=-
20), and the right insula (Talairach coordinates x=48, y=-4, z=-2). Recognition on the 
TOP10, however, was not significantly correlated with gray matter volume in any region. 
 
INSERT SUPPLEMENTARY FIG. S1, S2, S3A AND S3B ABOUT HERE 
 
 
3.3. FDG-PET data 
TOP10 total performance (semantic memory) was positively correlated with the PET 
metabolism of left posterior middle temporal gyrus (BA39; k=215; T-score=3.3; p-
voxel=0.001; Talairach coordinates x=-48, y=-63, z=25) (Figure 4B). RL/RI16 
performance (verbal anterograde memory) and DMS48 performance (visual anterograde 
memory) were not significantly correlated with PET metabolism in any brain region. 
 
INSERT FIG. 4B ABOUT HERE 




The principal goal of this study was to compare the neuropsychological profiles of early-
onset and late-onset Alzheimer’s disease patients in order to document the patterns of 
memory impairment specific to each group. A secondary goal was to compare group 
performance across cognitive domains, and to carry out VBM and FDG-PET analyses in 
order to investigate the relationships between patterns of cortical atrophy and brain 
metabolism and the memory impairment in these patients. Results indicate that when 
compared to their respective matched healthy control groups, EOAD and LOAD patients 
were significantly impaired in most cognitive domains examined, including episodic 
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memory, semantic memory, short term memory, working memory, executive functions, 
language, praxis and visuoconstructional abilities. A detailed analysis of functional 
integrity across memory subsystems showed common patterns of dysfunction as well as 
specific differences between groups. Verbal anterograde memory was very impaired in 
EOAD and LOAD, but the degree of impairment was equivalent in both groups. In 
contrast, a specific pattern of memory dysfunction emerged, revealing that semantic 
memory was significantly more affected in the LOAD than in the EOAD group. A more 
detailed analysis of the patterns of semantic impairment revealed that LOAD patients 
showed a more profound semantic impairment than EOAD patients, affecting both free 
recall and semantic recognition. No aspect of memory was more impaired in the EOAD 
than in the LOAD group, but results showed that the EOAD group showed significantly 
poorer performance in the domains of executive functions and visuoconstructional skills.  
Overall, results of this study show that there are distinct profiles of memory 
impairment associated with EOAD and LOAD. Contrary to previous studies which have 
reported a relative sparing of memory in EOAD (Binetti et al., 1996; Smits et al., 2012), 
results of the current study showed that EOAD patients presented with an important 
verbal episodic memory impairment, similar to that found in LOAD patients, even though 
patients in both groups were in a mild stage of dementia. Therefore, our results do not 
support the view that EOAD patients show a remarkable preservation of memory in the 
early stage of the disease and develop difficulties at later stages of the disease (Smits et 
al., 2012). Rather, they support the idea that the episodic memory impairment is present 
early in the disease process of EOAD, such as initially suggested by Delay and Brion 
(Adlam et al., 2006). The most novel finding of this study, however, was that LOAD 
patients showed prominent semantic memory deficits. This breakdown affecting both 
recall and recognition was evidenced using a semantic test which probed biographical 
knowledge about famous persons who had been famous between the 1950s and 2000s. 
Tests of famous person knowledge have been particularly useful in demonstrating 
semantic breakdown in AD but also in amnestic Mild cognitive impairment (aMCI) 
(Estevez-Gonzalez et al., 2004; Vogel et al., 2005; Joubert et al., 2008; Joubert et al., 
2010; Barbeau et al., 2012; Brambati et al., 2012). In fact, aMCI individuals have been 
found to be significantly more impaired at naming and providing information about 
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photographs of famous faces and famous monuments than about common objects 
(Ahmed et al., 2008; Joubert et al., 2010; Clague et al., 2011). Moreover, some studies 
have shown that aMCI individuals whose semantic knowledge of famous persons was 
most impaired had a higher rate of conversion to AD relative to non-converters 
(Thompson et al., 2002; Estevez-Gonzalez et al., 2004). Therefore, results of the present 
study suggest that there is a genuine and widespread semantic impairment in LOAD 
patients. This is particularly true considering that 100% of the LOAD patients were 
considered to be clinically impaired on the semantic test, as determined by a pathological 
cut-off of -1.96 standard deviations below the mean of the young control group. In 
contrast, only 50% of the EOAD patients reached this clinically significant cut-off. These 
results indicate that semantic breakdown may represent a clinically relevant and 
characteristic feature of LOAD. 
There was also a trend toward significance in regard to visual recognition memory 
(DMS48), LOAD patients performing more poorly than EOAD patients. It is worth to 
mention that the difference between EOAD and LOAD patients was marginally 
significant due to the severe correction of p values. Therefore, this difference may be 
genuine but lacking sufficient power. Visual recognition memory has been shown to be 
affected very early in AD and aMCI. The DMS48 specifically has been shown to be a 
very useful tool in the early detection of memory deficits in AD (Barbeau et al., 2004). 
Visual recognition memory is considered to be a “context-free” form of memory since it 
concerns an individual’s ability to recognize previously seen objects and shapes out of 
their context and it relies on a sense of familiarity rather than on recollection. Therefore, 
this type of memory is ridden of the spatial and temporal contextual information, and 
visual recognition memory is believed to rely on the integrity of subhippocampal 
structures such as the perirhinal cortex (Barbeau et al., 2004; Davies et al., 2004). 
Despite the fact that the DMS48 is a test of anterograde memory while the TOP 10 is a 
test of retrograde memory, both tests share some similarities in terms of the underlying 
memory processes, since semantic memory can also be considered to be context-free. 
Indeed, semantic memory allows accessing and retrieving conceptual knowledge that is 
free of contextual elements such as spatial and temporal cues. Therefore, it is conceivable 
that visual recognition memory and semantic memory may share some at least partly 
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overlapping common neuroanatomical grounds, including a network of interconnected 
temporal regions such as the perirhinal and entorhinal cortices as well as the anterior 
temporal lobe region (ATL) (Barbeau et al., 2012).  
Associations of gray matter volume (VBM) and brain metabolism (PET-FDG) with 
performance of EOAD and LOAD patients (combined in a single group) in three memory 
subdomains (TOP 10, DMS48, and RL/RI16 tests) did not allow identifying common 
brain regions between semantic memory and visual recognition memory. In fact, visual 
recognition memory (DMS48) and verbal anterograde memory (RL/RI16) did not 
correlate with gray matter volume and metabolism of any specific brain regions. In 
contrast, VBM analyses showed that poorer semantic performance in patients correlated 
positively with reduced gray matter volume in the left anterior and inferior temporal lobe 
region as well as in the right anterior temporal lobe, while FDG-PET analyses showed 
that poorer semantic performance correlated with greater hypometabolism in the left 
posterior middle temporal gyrus. Both of these regions are considered to be key regions 
of the semantic network. The anterior temporal lobe region has been described as a 
critical site for the convergence and processing of semantic information at an abstract and 
amodal level (Patterson et al., 2007; Lambon Ralph et al., 2009), and damage to this 
region has been suggested to result in a central loss of conceptual knowledge, affecting 
the identification and recognition of objects, persons and other classes of concepts across 
all sensory modalities. Alternately, Gainotti (Gainotti, 2014, 2015) also highlights the 
importance of the ATL region in his influential model of semantic memory, but unlike 
the unitary semantic hub hypothesis, suggests that lexical-semantic representations rely to 
a greater extent on the left ATL while non-verbal representations depend mainly on the 
right ATL. Results of the current study seem to fit with both conceptions.  
The left posterior middle temporal gyrus has also been identified as an important 
region of the semantic network (Whitney et al., 2012; Jefferies, 2013; Noonan et al., 
2013). More specifically, it has been recently suggested that this region plays a major role 
in the executive aspects of semantic cognition, including the manipulation and selection 
of task relevant knowledge as well as the inhibition of task-irrelevant knowledge. 
Therefore, the anterior temporal lobe region plays a more central role in semantic 
memory, whereas the left temporoparietal region plays a more important role in the 
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executive aspects of semantic processing. In this study, both regions correlated 
significantly with semantic performance, which suggests that both central processes and 
semantic control processes are affected in Alzheimer’s disease. 
In summary, the patterns of memory impairment in EOAD and LOAD patients 
indicate that LOAD were more impaired than EOAD patients on measures of semantic 
memory. The LOAD group was not more impaired than the EOAD group in any other 
cognitive domain. The EOAD group, however, was more impaired than the LOAD group 
in other cognitive domains such as executive functions and visuoconstructional skills. 
The EOAD group also performed more poorly on praxis, even though the difference was 
not statistically significant. This difference, however, may be genuine but lacking 
sufficient power due to the strict Bonferroni correction applied. No significant differences 
between EOAD and LOAD groups were observed in terms of language abilities, 
visuospatial skills, and visuoperceptual skills. One finding of this study which differs 
from previous reports is that visuospatial skills were not found to be disproportionately 
impaired in the EOAD group. This contrasts with several previous studies which have 
reported more important visuospatial deficits in EOAD patients (Fujimori et al., 1998; 
Koedam et al., 2010). In the present study, however, visuoconstructional skills were 
severely affected in EOAD patients when compared to LOAD patients, such as measured 
by performance on the copy of the Rey-Osterrieth Figure. Although this test involves the 
manipulation of spatial information and is often used as a measure of visuospatial 
integrity, it also involves motor skills as well as the implementation of executive 
functions (planning, structuring, coordination, and execution). The multifaceted nature of 
this test in terms of the underlying cognitive processes involved and the underlying 
executive function deficits in EOAD patients may therefore account for the severe 
difficulties encountered by the EOAD group on this test. This severely compromised 
performance in the EOAD group contrasted with preserved performance on another test 
of visuospatial function, the Benton line orientation test, which may be considered as a 
“purer” test of visuospatial integrity than the copy of the Rey-Osterrieth Figure. In 
summary, visuospatial skills may not be as severely compromised in EOAD as has been 
previously suggested in the literature.  
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In terms of language, our findings do not support the claim that EOAD patients 
present with significantly greater language impairment, such as has been suggested in 
previous studies (Chui et al., 1985; Filley et al., 1986; Becker et al., 1988; Faber-
Langendoen et al., 1988; Binetti et al., 1996; Imamura et al., 1998). In this study, 
composite scores were derived from tests that covered several aspects of expressive and 
receptive language including picture naming, speech, category fluency, repetition, and 
comprehension. When looking at Figure 2, the EOAD group showed greater language 
impairment when compared to the LOAD group, such as expressed by the mean z-scores, 
but this difference was not statistically different. This is due to the important within-
group variability (i.e. large standard deviations) in the EOAD group. Therefore, although 
some EOAD patients were clearly very impaired on language tasks, this was not the case 
for all EOAD patients. These results highlight the heterogeneity of language deficits in 




In conclusion, this study provides new insights into the nature of the cognitive decline in 
young and late-onset Alzheimer’s disease patients. EOAD and LOAD groups were 
strictly matched for disease severity and were recruited in an early stage of the disease. 
They were also matched for gender and education. EOAD and LOAD patients showed 
strong supporting evidence of Alzheimer’s disease using biomarkers, and both groups did 
not differ significantly in terms of biomarker values or in terms of ApoE4 status. Results 
indicate that both groups of patients present with significant memory impairment, but that 
distinct patterns of memory deficits emerge. LOAD patients were found to be 
significantly more impaired than EOAD patients solely in the memory domain (Jacobs et 
al., 1994; Koss et al., 1996). More specifically, LOAD patients presented with greater 
semantic memory deficits. In contrast, EOAD were found to be significantly more 
affected in non-memory domains including executive functions and visuoconstructional 
abilities. Contrary to previous studies, however, EOAD patients were not found to be 
more impaired in the language and visuospatial domains. Semantic deficits in AD 
patients were found to be associated with gray matter volume reduction in the left 
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anterior temporal lobes and with greater hypometabolism in the left temporoparietal 
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Table 1. Patient characteristics, Apo E4 frequency and biomarker values (mean and SD).   
patient characteristics EOAD LOAD 
Age 60.6 (5.2) 77.9 (4.7) 
Gender 12F/8M 12F/8M 
Education 11.6 (2.7) 11.3 (3.5) 
MMSE 21 (3.7) 22 (3.2) 
Years since onset of disease 2.9 (1.0) 2.8 (1.2) 
ApoE E4 homozygote 2 2 
ApoE E4 heterozygote 14 8 
CSF biomarkers   
Tau protein total 587.0 (278) 550.1 (267) 
Phospho Tau 181 104.5 (35) 87.7 (31) 
Amyloid 423.4 (122) 379.1 (122) 










Table 2. Neuropsychological assessment of EOAD, LOAD, and healthy controls. 






EOAD    
vs. LOAD
EOAD    
vs.  YCTR
LOAD       
vs. OCTR
General cognitive functioning
MMSE 20.7 (3.7) 22.0 (3.2) 29.2 (0.9) 29.2 (0.6) n.s. * * †
FAB 12.7 (3.3) 13.1 (3.3) 17.5 (0.8) 17.5 (0.9) n.s. * † * †
Memory
Verbal anterograde memory
RL/RI 16 Immediate Free Recall (48) 5.3 (5.8) 4.6 (4.9) 33.1 (5.6) 32.4 (5.1) n.s. * *
RL/RI 16 Immediate Total Recall (48) 17.3 (11.7) 19.9 (12.2) 46.1 (2.6) 46.1 (1.5) n.s. * † *
RL/RI 16 Delayed Free Recall (16) 0.9 (1.5) 1 (1.7) 13.4 (1.7) 12.9 (2.0) n.s. † * * †
RL/RI 16 Delayed Total Recall (16) 4.4 (4.1) 6.4 (3.6) 15.9 (0.5) 15.8 (0.4) n.s. * † * †
Visual anterograde memory
DMS 48 Immediate (2 min) 82.9 (15.1) 78.4 (12.3) 96.2 (3.1) 94.9 (5.9) n.s. * *
DMS 48 Delayed (1 hour) 82.2 (16.5) 72.7 (14.2) 95.7 (5.1) 95.6 (4.3) n.s. n.s. *
Short term and working memory
Verbal forward digit span (WAIS-III) 4.5 (1.2) 4.6 (1.2) 4.9 (0.9) 4.5 (1.1) n.s. n.s. n.s.
Verbal backward digit span (WAIS-III) 2.5 (1.0) 2.8 (0.9) 3.6 (0.7) 3.7 (0.7) n.s. * † n.s. †
Spatial forward span (WMS-III) 3.0 (0.8) 3.4 (1.0) 5.0 (1.0) 4.0 (0.7) n.s. * n.s. †
Spatial backward span (WMS-III) 2.7 (1.0) 2.7 (0.8) 4.0 (0.9) 3.7 (0.7) n.s. † * † *
Semantic retrograde memory
TOP 10 picture naming (20) 10.1 (3.4) 4.5 (2.9) 16.3 (3.4) 14.0 (3.6) * * *
TOP 10 semantic free recall (20) 8.8 (4.2) 3.6 (2.6) 16.2 (4.0) 16 (2.8) * * *
TOP 10 semantic recognition (10) 9.2 (1.2) 7.2 (1.5) 9.6 (0.8) 9.4 (0.6) * † n.s. † *
TOP 10 Time (10) 3.8 (1.7) 2.5 (1.8) 7.4 (2.6) 7.5 (2.4) n.s. * *
TOP 10 Total (60) 31.9 (8.7) 17.8 (6.8) 49.5 (8.6) 46.7 (7.9) * * *
Attention. speed of processing and executive functions
Coding (WAIS-III) 40.9 (23.2) 29.5 (14.1) 65.8 (14.1) 54.0 (12.2) n.s. * *
TMT Part A (Time in sec.) 77 (45) 121 (177) 35.8 (11.4) 51.0 (17.3) n.s. † * n.s. †
TMT Part A (errors) 0 0 0.2 (0.4) 0.2 (0.4) n.s. † n.s. † n.s. †
TMT Part B (Time in sec.) 268 (106) 191 (68) 74.9 (17.6) 115.4 (29.3) n.s. * *
TMT Part B (errors) 3.0 (3.1) 1.2 (1.2) 0.3 (0.6) 0.8 (0.9) n.s. n.s. † n.s.
WCST (Nelson) categories 3.5 (1.7) 3.5 (1.9) 5.9 (0.3) 5.4 (1.1) n.s. * † n.s. †
WCST (Nelson) errors 15.6 (8.4) 15.0 (8.1) 4.8 (3.6) 6.7 (4.6) n.s. * † *
Letter P fluency (2 min) 15.3 (6.2) 15.0 (6.5) 19.5 (4.9) 18.8 (5.3) n.s. n.s. n.s.
Language
Picture naming
DO80 picture naming test (80) 73.7 (5.6) 71.3 (8.2) 79.9 (0.2) 79.9 (0.3) n.s. * † * †
Fluency
Animals (2 min) 13.6 (6.3) 15.4 (7.5) 30.2 (5.9) 28.4 (6.4) n.s. * *
Speech
MEC spontaneous speech (34) 27.8 (3.9) 27.0 (5.9) 34.0 (0.2) 33.9 (0.4) n.s. * † * †
Repetition
Concrete sentences (8) 7.4 (1.5) 7.3 (1.4) 8.0 (0.2) 7.9 (0.5) n.s. † n.s. † n.s. †
Abstract sentences (8) 6.4 (1.8) 5.7 (2.5) 7.9 (0.3) 7.9 (0.3) n.s. n.s. † n.s. †
Comprehension
HDAE Logic and reasoning (12) 7.5 (3.2) 8.1 (3.1) 11.5 (0.6) 11.2 (0.9) n.s. * † *
HDAE Verbal commands (15) 11.8 (4.1) 13.0 (3.7) 14.8 (0.6) 14.6 (0.9) n.s. n.s. † n.s. †
HDAE Verbal discrimination (72) 66.4 (5.6) 66.8 (4.2) 71.9 (0.2) 71.7 (0.6) n.s. * † * †
Praxis
Symbolic (5) 4.1 (1.1) 4.5 (1.0) 5.0 (0.2) 4.9 (0.4) n.s. † n.s. n.s. †
Actions (10) 8.2 (2.6) 8.8 (1.8) 10 (0.2) 9.9 (0.3) n.s. * n.s. †
Abstract (8) 5.0 (2.4) 5.1 (1.6) 7.9 (0.5) 7.3 (0.9) n.s. * † * †
Visuoconstructional abilities
Rey Figure copy - score (36) 15.4 (14.7) 22.5 (12.4) 34.6 (1.3) 33.4 (3.2) n.s. * *
Rey Figure copy - time (36) 234 (99) 268 (85) 139 (43) 190 (102) n.s. * n.s.
Visuospatial abilities
Benton Line Orientation Test (30) 15.6 (8.0) 18.4 (7.6) 22.9 (3.3) 22.5 (3.8) n.s. * n.s.
Visuoperceptual abilities
Benton Facial Recognition Test (27) 20.4 (2.7) 20.1 (1.8) 21.4 (1.8) 20.5 (3.3) n.s. n.s. n.s.
values indicate mean scores and standard deviations in brackets
n.s. = non significant
* = statistically significant difference, p < 0.0013 (Bonferroni correction applied)




                   
Figure 1. Mean composite z-scores for memory subdomains in EOAD and LOAD groups. Semantic 
memory was found to be significantly more impaired in the LOAD group than in the EOAD group, while 
no memory subdomain was more impaired in the EOAD than in the LOAD group (significance was set at 
p<0.007 after Bonferroni correction). Verbal anterograde memory was equally affected in both groups. 
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Figure 2. Mean composite z-scores for non-memory cognitive domains in EOAD and LOAD groups. The 
EOAD group was significantly more impaired than the LOAD group in executive functions and 
visuoconstructional abilities. The LOAD was not more impaired than the EOAD group in any cognitive 
domain (significance was set at p<0.008 after Bonferroni correction). 
 























Figure 3. Semantic performance of EOAD (top row) and LOAD (bottom row) groups and their respective 
control groups on the TOP 10. Results show that LOAD patients were impaired both on the semantic free 
recall and recognition tasks, while EOAD were impaired only on the semantic free recall task. These results 































































Figure 4A. Voxel-based Morphometry (VBM) results (multiple regression with age, educational level and 
gender as confounding variables (p<0.005, FDR corrected at the cluster level p<0.05) showing that semantic 
memory performance (TOP 10 total score) was positively correlated with gray matter volume of left inferior 






Figure 4B. Semantic memory performance (TOP10 total score) was positively correlated with the PET 










Supplementary data  
Figure S1 
Voxel-based Morphometry (VBM) results (p<0.005, FDR corrected at the cluster level p<0.05) 
showing a positive correlation between free recall performance on the TOP 10 and gray matter 





Supplementary data  
Figure S2  
Voxel-based Morphometry (VBM) results (ANOVA with age, educational level and gender as 
confounding variables) (p<0.005, FDR corrected at the cluster level p<0.05) showing patterns of 



















Supplementary data  
Figure S3A 
Voxel-based Morphometry (VBM) results (p<0.005, FDR corrected at the cluster level p<0.05) 
showing patterns of atrophy in EAOD relative to age- and education-matched younger controls. 






Supplementary data  
Figure S3B 
Voxel-based Morphometry (VBM) results (p<0.005, FDR corrected at the cluster level p<0.05) 
showing patterns of atrophy in LOAD relative to age- and education-matched older controls. 
Patterns of atrophy predominate mainly in the temporal lobes with a significant but moderate 





Supplementary data  
Figure S4 
Whole-brain PET statistical analysis (ANOVA with age, educational level and gender as 
confounding variables (p<0.005, FDR corrected at the cluster level p<0.05) showing patterns of 
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